A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, demonstrating high sensitivity for both malignant and advanced precancerous lesions ...
A new blood test that screens for colorectal cancer has just been approved by the Food and Drug Administration (FDA). The blood sample needed for the new test, called Shield, can be obtained at a ...
Saga Diagnostics expanded the use of its ultrasensitive blood test to include detection of tiny amounts of colorectal cancer ...
Rhythm Biosciences Ltd ('RHY', the 'Company' or the 'Group') (ASX: RHY), a transformative, predictive cancer diagnostics technology company is pleased to announce the commercial launch of its updated ...
10d
Rhythm Biosciences enhances geneType colorectal cancer test with clinical and lifestyle risk factors
Rhythm Biosciences has materially improved the predictive accuracy of its geneType colorectal cancer risk assessment clinical ...
CITCCA data demonstrate more than 40% of high-risk stage I–III colorectal patients harbor molecular residual disease at clinical landmark, detectable only with ultrasensitive ctDNA testingMORRISVILLE, ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for ...
Money Talks News on MSN
This at-home test detects cancer as effectively as a colonoscopy
Screening for colorectal cancer could become much cheaper and less invasive.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback